eFFECTOR Therapeutics, Inc. Common Stock
eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view EFTR Smart Score
eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs). Show Less
Recent trades of EFTR by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by EFTR's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to EFTR
Recent picks made for EFTR stock on CNBC
ETFs with the largest estimated holdings in EFTR
Flights by private jets registered to EFTR